Ensayos clínicos de Obesidad en Kentucky
30 estudios sobre Obesidad buscan participantes en Kentucky.
Ciudades en Kentucky
Texto oficial del estudio (inglés)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Monroe Biomedical Research, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07351045Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Lexington, Lexington
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT07685808A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT07845500A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical - Bowling Green, Bowling Green
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Norton Children's Endocrinology, Louisville
ReclutandoFase 3
Edades de 6 a 11 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- AMR Clinical, Lexington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Health Partners, Louisville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Health Partners, Louisville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Norton Children's Endocrinology, Louisville
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06672549Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- The Alliance for Multispecialty Research - Lexington, Lexington
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Owensboro
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- The Research Group of Lexington LLC, Lexington
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 29 oct 2026 · NCT07037459Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- L-MARC Research Center /ID# 282008, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 oct 2026 · NCT07752979MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
- University of Kentucky, Lexington
Reclutando
Edades de 12 a 17 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07478653A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 7 oct 2026 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Louisville Metabolic and Atherosclerosis Research Center, Louisville
ReclutandoFase 3
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 oct 2026 · NCT07684235Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- L-MARC Research Center, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07770841A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- The Alliance for Multispecialty Research LLC AMR, Lexington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07745504The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
- University of Kentucky, Lexington
ReclutandoFase 4Se aceptan voluntarios sanos
Edades de 35 a 65 · Todos los sexos · Actualizado el 31 ago 2026 · NCT05051436A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- The Research Group of Lexington LLC, Lexington
- UofL Health Care Outpatient, Louisville
- Research Integrity Global, LLC, Owensboro
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07567001AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Monroe Biomedical Research, LLC, Louisville
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Louisville
ReclutandoFase 3
Edades de 18 a 79 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07654361Cannabis for Obesity Trial
- University of Kentucky, Lexington
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 7 ago 2026 · NCT06137365Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- University of Kentucky, Lexington
ReclutandoEstudio observacional
Edades de 12 a 17 · Todos los sexos · Actualizado el 21 jul 2026 · NCT06967389A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
- Monroe Biomedical Research, Louisville
ReclutandoFase 2
Edades de 18 a 60 · Todos los sexos · Actualizado el 22 jun 2026 · NCT07570758A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
- MBX Biosciences Investigational Site, Lexington
ReclutandoFase 1
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 jun 2026 · NCT071427072024 Tirzepatide-Bariatric Surgery
- University of Kentucky, Lexington
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 may 2026 · NCT06721507Adrenergic Cholinergic Enteric Measures/Mapping
- University of Louisville, Louisville
ReclutandoEstudio observacional
Edades de 10 a 80 · Todos los sexos · Actualizado el 10 ene 2025 · NCT04013282De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.